PF-07921585 is under clinical development by Pfizer and currently in Phase I for Metastatic Colorectal Cancer.

Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

Nearly 200 nations at the Cop28 climate summit in Dubai agreed to the deal, which calls on them to "transition away" from ... who had called for the term "phase out" of fossil fuels to be used ...

Deconfined quantum criticality represents a novel class of phase transitions that fall outside ... material candidates show a weakly-first order transition. Here the authors introduce a Nordic ...